Recurrence of Melanoma

被引：1
作者：
Vidal-Sicart, Sergi [1 ,2 ,3 ]
Rubello, Domenico [4 ]
Pons, Francesca [1 ,2 ]
机构：
[1] Univ Barcelona, Hosp Clin, Dept Nucl Med, Villarroel 170, E-08036 Barcelona, Spain
[2] IDIBAPS, Barcelona 08036, Spain
[3] Corp Sanitaria, Dept Nucl Med, CRC MAR, Barcelona 08003, Spain
[4] Santa Maria della Misericordia Hosp, Dept Nucl Med, I-45100 Rovigo, Italy
来源：
PET CLINICS | 2011年 / 6卷 / 01期
关键词：
Melanoma; Positron emission tomography (PET); Computed tomography (CT); PET/CT; Recurrence;
D O I：
10.1016/j.cpet.2010.12.004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
When cutaneous melanoma recurrence is suspected, several imaging techniques can be used to confirm or rule out this possibility as well as performing an adequate follow-up of the disease. [F-18] Fluorodeoxyglucose (FDG)-PET may play an important role in this setting. Ultrasonography and FDG-PET can be useful in the assessment of regional node involvement but sentinel node biopsy is the gold standard. PET/ computed tomography is most useful for identifying all metastatic sites before embarking on a metastasectomy of an apparently isolated lesion or for clarifying the nature of a suspicious lesion identified by CT scan.
引用
收藏
页码：55 / 70
页数：16
相关论文
共 50 条
  • [31] Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
    Dalal, Kimberly M.
    Patel, Ami
    Brady, Mary S.
    Jaques, David P.
    Coit, Daniel G.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) : 1934 - 1942
  • [32] Recurrence of Melanoma After Initial Treatment: Diagnostic Performance of FDG PET in Posttreatment Surveillance
    Lee H.H.
    Paeng J.C.
    Cheon G.J.
    Lee D.S.
    Chung J.-K.
    Kang K.W.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (5) : 327 - 333
  • [33] Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients
    de Menezes, Jacqueline N.
    Arra, Dante A. S. M.
    Lobo, Matheus M.
    Pinto, Clovis A. L.
    Lima, Joao P. S. N.
    Silva, Milton J. B.
    Duprat Neto, Joao P.
    Bertolli, Eduardo
    CANCER INVESTIGATION, 2023, 41 (10) : 830 - 836
  • [34] Clinical Outcomes of Isolated Regional Lymph Node Recurrence in Patients With Malignant Cutaneous Melanoma
    Kwon, Jeanny
    Kim, Young A.
    Lee, Cheol
    Kim, Byoung Hyuck
    Kim, Suzy
    Kim, Il Han
    ANTICANCER RESEARCH, 2019, 39 (06) : 3147 - 3157
  • [35] Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance
    Bleicher, Josh
    Swords, Douglas S.
    Mali, Meghan E.
    McGuire, Lauren
    Pahlkotter, Maranda K.
    Asare, Elliot A.
    Bowles, Tawnya L.
    Hyngstrom, John R.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (08) : 1770 - 1777
  • [36] Descriptive Analysis of Cutaneous Recurrence Patterns in Patients with Melanoma
    Marcoval, J.
    Ferreres, J. R.
    Penin, R. M.
    Piulats, J. M.
    Caminal, J. M.
    Fabra, A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (10): : 791 - 796
  • [37] Risk factors for nodal recurrence after lymphadenectomy for melanoma
    Pidhorecky, I
    Lee, RJ
    Proulx, G
    Kollmorgen, DR
    Jia, CY
    Driscoll, DL
    Kraybill, WG
    Gibbs, JF
    ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) : 109 - 115
  • [38] Breast metastases as the first sign of recurrence of a cutaneous melanoma
    Gimeno T.S.
    Antón F.M.
    Cobo S.L.-T.
    Larriba J.L.G.
    Bacete V.F.
    García E.D-R.
    Clinical and Translational Oncology, 2006, 8 (1) : 57 - 59
  • [39] Recurrence of treated ciliary body melanoma following trabeculectomy
    Tay, Eugene
    Cree, Ian A.
    Hungerford, John
    Franks, Wendy
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (05) : 503 - 505
  • [40] Recurrence of nevoid melanoma originally diagnosed as benign nevus
    Collina, G.
    Reggiani, C.
    PATHOLOGICA, 2009, 101 (03) : 112 - 114
12345